Does nicotine protect against coronavirus?
New study suggests smoking may cut risk of infection - but does not advise taking up the fatal habit
Coronavirus patients and front-line medics are to be given nicotine patches in clinical trials to see whether smoking may cut the risk of contracting the Covid-19 coronavirus.
The move comes after a newly published French study found that the proportion of smokers who tested positive for the infection was much lower than that in the general population.
The trials are awaiting the approval of France’s health authorities, The Guardian reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What does the study say?
Researchers from the Pitie-Salpetriere Hospital and Universite Pierre et Marie Curie in Paris questioned 480 patients confirmed to have the new coronavirus, of whom 350 were hospitalised, while the rest were allowed home.
The analysis found that of those admitted to hospital, 4.4% were regular smokers, with a median age of 65. Among those sent home, 5.3% smoked, with a median age of 44.
By comparison, among the general population, smokers make up around 40% of people between the ages of 44 and 53, and around 11% of those aged 65 to 75, according to estimates by the French health authority.
And figures from hospitals across the French capital show that of 11,000 patients of all ages admitted to hospital with Covid-19, 8.5% were smokers. The total number of smokers in France is estimated at around 25.4%.
The study authors write: “Our cross-sectional study strongly suggests that those who smoke every day are much less likely to develop a symptomatic or severe infection with Sars-CoV-2 compared with the general population.
“The effect is significant. It divides the risk by five for ambulatory patients and by four for those admitted to hospital. We rarely see this in medicine.”
Neurobiologist Jean-Pierre Changeux, who reviewed the study, has suggested that nicotine in cigarettes may hinder the virus from entering the body’s cells.
Experts say that the chemical may also “lessen the overreaction of the body’s immune system that has been found in the most severe cases of Covid-19 infection”, The Guardian adds.
Has this link been made before?
Yes, other studies have also revealed a lower rate of coronavirus infection among smokers.
For example, a study published in the New England Journal of Medicine in February found that smokers accounted for 12.6% of a sample of 1,100 Covid-19 patients in China, despite making up around 28% of the general population.
However, some experts believe that cigarettes can increase the risk of contracting the disease.
The US Food and Drug Administration (FDA) told Bloomberg this week that “people who smoke cigarettes may be at increased risk of infection with the virus that causes Covid-19, and may have worse outcomes from Covid-19”.
–––––––––––––––––––––––––––––––For a round-up of the most important stories from around the world - and a concise, refreshing and balanced take on the week’s news agenda - try The Week magazine. Start your trial subscription today –––––––––––––––––––––––––––––––
‘Fatal health risks’
Although the Paris researchers’ findings suggest that nicotine may help fend off the coronavirus, “the team says it is not advocating that anyone start smoking, because cigarettes have fatal health risks”, the Daily Mail reports.
As The Guardian notes, smoking is estimated to kill around 50% of people who take up the habit.
The newspaper also points out that the French experts emphasise that “while nicotine may protect those from the virus”, smokers who do become infected often develop more serious symptoms because of the damaging effects of tobacco smoke on their lungs.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Why Māori are protesting in New Zealand
A controversial bill has ignited a 'flashpoint in race relations' as opponents claim it will undermine the rights of Indigenous people
By Richard Windsor, The Week UK Published
-
Crossword: November 21, 2024
The Week's daily crossword
By The Week Staff Published
-
Sudoku hard: November 21, 2024
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published